In the latest trading session, 0.78 million Geron Corp. (NASDAQ:GERN) shares changed hands as the company’s beta touched 0.50. With the company’s most recent per share price at $3.95 changing hands around $0.0 or 0.13% at last look, the market valuation stands at $2.38B. GERN’s current price is a discount, trading about -35.19% off its 52-week high of $5.34. The share price had its 52-week low at $1.64, which suggests the last value was 58.48% up since then. When we look at Geron Corp.’s average trading volume, we note the 10-day average is 7.81 million shares, with the 3-month average coming to 8.85 million.
Analysts gave the Geron Corp. (GERN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.11. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended GERN as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight. Geron Corp.’s EPS for the current quarter is expected to be -0.08.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Geron Corp. (NASDAQ:GERN) trade information
Instantly GERN is in green as seen in intraday trades today. With action -5.61%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 87.44%, with the 5-day performance at -5.61% in the red. However, in the 30-day time frame, Geron Corp. (NASDAQ:GERN) is -7.59% down. Looking at the short shares, we see there were 81.03 million shares sold at short interest cover period of 9.04 days.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 34.17% from its recent market value. According to analyst projections, GERN’s forecast low is 4.5 with 7 as the target high. To hit the forecast high, the stock’s price needs a -77.22% plunge from its current level, while the stock would need to soar -13.92% for it to hit the projected low.
Geron Corp. (GERN) estimates and forecasts
Data shows that the Geron Corp. share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 13.00% over the past 6 months, a -6.25% in annual growth rate that is considerably lower than the industry average of 17.20%. Year-over-year growth is forecast to reach 24,085.70% up from the last financial year.
Consensus estimates given by 8 financial analysts project the company’s revenue in the current quarter to hit an average of 18.97M. 8 analysts are of the opinion that Geron Corp.’s revenue for the current quarter will be 37.36M. The company’s revenue for the corresponding quarters a year ago was 164k and 23k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 11,467.10%. The estimates for the next quarter sales put growth at 162,334.80%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -16.08%. The 2024 estimates are for Geron Corp. earnings to decrease by -6.25%, but the outlook for the next 5-year period is at 5.00% per year.
GERN Dividends
Geron Corp. is expected to release its next quarterly earnings report on 2024-Nov-07.
Geron Corp. (NASDAQ:GERN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.09% of Geron Corp. shares while 77.95% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 78.02%. There are 77.95% institutions holding the Geron Corp. stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 7.7138% of the shares, roughly 46.55 million GERN shares worth $197.38 million.
RA CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 7.6558% or 46.2 million shares worth $195.9 million as of 2024-06-30.
Among Mutual Funds, the top two as of Jun 30, 2024 were Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. With 17.81 shares estimated at $69.98 million under it, the former controlled 2.95% of total outstanding shares. On the other hand, SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF held about 2.66% of the shares, roughly 16.03 shares worth around $63.0 million.
